Novo Holdings invests in proteomics technology company, Evosep

/in , /by

COPENHAGEN, Denmark — Novo Holdings, a leading international life science investor, today announced a $40m investment in Evosep, the bioscience company leading the standardisation of proteomics for clinical use. The proceeds from the investment by Novo Holdings will be used to advance clinical applications of proteomics enabled by Evosep’s standardised liquid chromatography platform. The new funds will […]

Read more →

ChromaTwist lands funding to develop fluorescent dyes for the flow cytometry market

/in , , , /by

The University of Birmingham spinout has secured £487k of equity investment to develop its new class of fluorescent dyes for flow cytometry. University of Birmingham spinout ChromaTwist Ltd has secured £487k of equity investment to develop its new class of fluorescent dyes for the flow cytometry reagent market. This second round of equity investment, which brought in […]

Read more →

Semarion raises £2.14 million GBP ($2.89 million USD) seed funding

/in , /by

Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodologies Investors include Parkwalk Advisors, University of Cambridge Seed Funds, Martlet Capital, and angel investors Cambridge, UK: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory […]

Read more →

Proxima Ventures and Co-win Ventures invest in Bioelectronica® Corporation to accelerate pharmaceutical discovery and development

/in /by

RENO, Nev.— Bioelectronica Corporation (“Bioelectronica”) today announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company’s innovations in digital biochemistry, from novel assay development to scalable electrofluidics. The Series A investment was led by Proxima Ventures with follow-on investment by Co-win Ventures. The team at Proxima, experienced investors in […]

Read more →

SomaLogic Awarded Grant from National Science Foundation Convergence Accelerator

/in , , , /by

Funding will support development of novel proteomic devices based on quantum sensing BOULDER, Colo., October 13, 2020 — SomaLogic, Inc. announced today that a collaborative project between SomaLogic scientists and academic researchers at the University of Chicago, University of California, Los Angeles, University of California, Santa Barbara, and University of Washington, Seattle has received a […]

Read more →

Genemod Raises $1.7M in Oversubscribed Seed Round to Drive the Next Generation of Medicine

/in , /by

Seed round led by Defy.vc; Genemod to expand product offering and scale team SEATTLE — Genemod, a software solution for life scientists that uses data automation to streamline and accelerate research, today announced a $1.7M seed funding round led by Defy.vc with added support by Omicron, Unpopular Ventures, Underdog Labs, and Canaan Partners Scout Fund. The funding will enable Genemod to now include a complimentary […]

Read more →